-
Drug Marketing in China and Worldwide (October)(2023)
PharmaSources
November 01, 2023
Drugs have been approved for marketing, and some diseases have been treated.
-
Pharmaceutical Business in China and Worldwide (September)(2023)
PharmaSources
October 01, 2023
Pharmaceutical companies reached a cooperation agreement and began to commercialize drugs for the treatment of diseases.
-
Drug Marketing in China and Worldwide (August)(2023)
PharmaSources
September 01, 2023
The official website shows that the drugs developed by major companies have been declared for marketing.
-
Pharmaceutical Business in China and Worldwide (July)
Caicai/PharmaSources
August 11, 2023
On July 11th, KELUN Biotech was officially listed on the Hong Kong Stock Exchange.
-
Pharmaceutical Business Progress in China and Worldwide (March)
PharmaSources
May 12, 2023
Progress in Pharmaceutical Business at Home and Abroad (March)
-
Weekly Pharma News Review | PharmaSources.com (1017-1021)
PharmaSources.com
October 24, 2022
The news review of this week is from October 17 to 21, covering a total of 21 pieces of information in 3 sections, i.e., drug review, R&D, and listing.
-
Weekly Pharma News Review | PharmaSources.com (0919-0923)
PharmaSources.com
September 26, 2022
The news reviewed this week is from September 19 to 23, covering a total of 25 pieces of information in 4 sections, i.e. drug review, R&D, and business and listing.
-
Weekly Pharma News Review | PharmaSources.com (0829-0902)
PharmaSources.com
September 06, 2022
This week, the second biological drug developed by SinoCellTech - ripertamab, a new anti-CD20 monoclonal antibody, was approved for marketing, which aroused the attention of the industry. The news review of this week is from August 29 to September 2.
-
Weekly Pharma News Review | PharmaSources.com (April 11 to 15)
Yefenghong
April 20, 2022
The sharp crushing in the stock prices of Chinese vaccine leader companies Zhifei Biological and Wantai Biological is the most-watched news this week.
-
Pharmaceutical News of the Week | CPhI.CN - Listing
PharmaSources/Caicai
August 06, 2020
Eyebright was successfully listed on the SSE STAR Market on July 29.